IL17A and systemic lupus erythematosus: Consistently, recent study showed that down-regulation of IL-17 production by T cells was correlated with the amelioration of murine lupus after treatment with either low-dose peptide tolerance therapy or nasal anti-CD3 antibody [32], [33].